Analyst price target range
AbbVie Price Target: $276.59 Average
Direct answer
AbbVie's average price target is $276.59.
The verified analyst range runs from $200.00 to $328.00.
The low target implies -20.3%, the high target implies +30.7%, and the range spans 51% of the current price.
Forecast evidence checked September 8, 2026.
Get free AbbVie email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $250.96
- Average price target
- $276.59
- High price target
- $328.00
- Low price target
- $200.00
- Low target gap
- -20.3%
- Target upside
- +10.2%
- High target gap
- +30.7%
- Target range width
- 51%
- Consensus rating
- Buy
- Analysts
- 29
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is AbbVie's average price target?
AbbVie's verified average price target is $276.59. The target range is $200.00 to $328.00.
How far are AbbVie's low and high targets from the recorded price?
The low target implies -20.3%, while the high target implies +30.7%.
How many analysts are included in AbbVie's consensus?
The verified consensus includes 29 analysts.
How is AbbVie's target upside or downside calculated?
The average target of $276.59 is divided by the recorded price of $250.96, then one is subtracted to produce +10.2%. This does not guarantee a future return.
When was AbbVie's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.